检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张曼丽 李卫东 Man-li Zhang;Wei-dong Li(Department of Thyroid Breast Surgery,Cangzhou People's Hospital,Cangzhou,Hebei 061000,China)
机构地区:[1]河北省沧州市人民医院甲状腺乳腺外科,河北沧州061000
出 处:《中国现代医学杂志》2018年第36期58-63,共6页China Journal of Modern Medicine
基 金:河北省科技计划项目(No:JB0015277792D)
摘 要:目的研究甲状旁腺切除联合自体移植(tPTX+AT)对继发性甲状旁腺功能亢进(SHPT)尿毒症患者的疗效及对左心室肥厚、血清胎球蛋白A(Fetuin-A)、炎症因子的影响。方法 74例SHPT尿毒症患者被随机分为两组,每组37例。对照组行常规治疗,观察组在此基础上行t PTX+AT术。术后6个月比较两组患者甲状旁腺激素(i PTH)、血清钙、磷浓度变化,采用超声心动图检测左心室肥厚的指标变化情况,检测治疗前后血清Fetuin-A、超敏C-反应蛋白(hs-CRP)水平及白细胞介素6(IL-6)水平。结果术后6个月随访,观察组的血清钙、血清磷、钙磷乘积以及i PTH均下降(P <0.05),对照组上述指标变化差异无统计学意义(P>0.05)。观察组舒张末期室间隔厚度(IVST)、左心室重量指数(LVMI)、左心室后壁厚度(LVPWT)均下降,左心室射血分数(LVEF)升高(P <0.05);钙化率变化差异无统计学意义(P>0.05)。对照组的IVST、LVMI、LVPWT变化差异无统计学意义(P>0.05);但钙化率升高(P <0.05)。观察组Fetuin-A升高,hs-CRP和IL-6水平下降(P <0.05);对照组变化差异无统计学意义(P>0.05)。结论 tPTX+AT术能有效降低SHPT尿毒症患者的血磷、血钙和i PTH浓度,改善临床症状及患者的左心室肥厚,延缓心脏瓣膜钙化进展,同时上调Fetuin-A浓度,下调IL-6和hs-CRP浓度。Objective To analyze the effect of total parathyroidectomy with autologous transplantation(tPTX+AT)in the treatment of secondary hyperparathyroidism(SHPT)uremia patients and influence on left ventricular hypertrophy and Fetuin-A.Methods Totally 74 SHPT uremia patients were involved in this study,and were randomly divided into control group and observation group(n=37).All patients were treated with standard therapy while patients in observation group received additional treatment of tPTX+AT.iPTH,serum concentration of calcium and phosphorus,Fetuin-A,IL-6 and hs-CRP were measured.Left ventricle was evaluated by echocardiographic test.Results Levels of iPTH,serum calcium and phosphorus,calcium-phosphorus product,hs-CRP and IL-6 in observation group were decreased and levels of fetuin-A were increased significantly(P<0.05),while those in control group did not show any obvious change(P>0.05).The IVST,LVMI and LVPWT in patients of observation group decreased while LVEF was increased dramatically(P<0.05).However,no alteration in IVST,LVMI,and LVPWT in control group was witnessed(P<0.05).Calcification rate did not show any change in observation group while that was increased obviously in control group.Conclusions tPTX+AT can improve the clinical symptoms,and delay the progression of cardiac valve calcification in patients with SHPT uremia.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222